BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 22525466)

  • 1. Ataxia-telangiectasia mutated and the Mre11-Rad50-NBS1 complex: promising targets for radiosensitization.
    Kuroda S; Urata Y; Fujiwara T
    Acta Med Okayama; 2012; 66(2):83-92. PubMed ID: 22525466
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ataxia-telangiectasia-like disorder (ATLD)-its clinical presentation and molecular basis.
    Taylor AM; Groom A; Byrd PJ
    DNA Repair (Amst); 2004; 3(8-9):1219-25. PubMed ID: 15279810
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular basis of ataxia telangiectasia and related diseases.
    Ball LG; Xiao W
    Acta Pharmacol Sin; 2005 Aug; 26(8):897-907. PubMed ID: 16038621
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Purification and biochemical characterization of ataxia-telangiectasia mutated and Mre11/Rad50/Nbs1.
    Lee JH; Paull TT
    Methods Enzymol; 2006; 408():529-39. PubMed ID: 16793391
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential DNA damage signaling accounts for distinct neural apoptotic responses in ATLD and NBS.
    Shull ER; Lee Y; Nakane H; Stracker TH; Zhao J; Russell HR; Petrini JH; McKinnon PJ
    Genes Dev; 2009 Jan; 23(2):171-80. PubMed ID: 19171781
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ATM as a target for novel radiosensitizers.
    Sarkaria JN; Eshleman JS
    Semin Radiat Oncol; 2001 Oct; 11(4):316-27. PubMed ID: 11677656
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Requirement of the MRN complex for ATM activation by DNA damage.
    Uziel T; Lerenthal Y; Moyal L; Andegeko Y; Mittelman L; Shiloh Y
    EMBO J; 2003 Oct; 22(20):5612-21. PubMed ID: 14532133
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ATM and the Mre11 complex combine to recognize and signal DNA double-strand breaks.
    Lavin MF
    Oncogene; 2007 Dec; 26(56):7749-58. PubMed ID: 18066087
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ATM-dependent phosphorylation of nibrin in response to radiation exposure.
    Gatei M; Young D; Cerosaletti KM; Desai-Mehta A; Spring K; Kozlov S; Lavin MF; Gatti RA; Concannon P; Khanna K
    Nat Genet; 2000 May; 25(1):115-9. PubMed ID: 10802669
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ataxia-telangiectasia mutated kinase (ATM) as a central regulator of radiation-induced DNA damage response.
    Tichý A; Vávrová J; Pejchal J; Rezácová M
    Acta Medica (Hradec Kralove); 2010; 53(1):13-7. PubMed ID: 20608227
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of an NBS1 C-terminal peptide that can inhibit ataxia telangiectasia mutated (ATM)-mediated DNA damage responses and enhance radiosensitivity.
    Cariveau MJ; Tang X; Cui XL; Xu B
    Mol Pharmacol; 2007 Aug; 72(2):320-6. PubMed ID: 17507690
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of MET by ionizing radiation and its role in radioresistance and invasive growth of cancer.
    De Bacco F; Luraghi P; Medico E; Reato G; Girolami F; Perera T; Gabriele P; Comoglio PM; Boccaccio C
    J Natl Cancer Inst; 2011 Apr; 103(8):645-61. PubMed ID: 21464397
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distinct functional domains of Nbs1 modulate the timing and magnitude of ATM activation after low doses of ionizing radiation.
    Horejsí Z; Falck J; Bakkenist CJ; Kastan MB; Lukas J; Bartek J
    Oncogene; 2004 Apr; 23(17):3122-7. PubMed ID: 15048089
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Telomerase-dependent oncolytic adenovirus sensitizes human cancer cells to ionizing radiation via inhibition of DNA repair machinery.
    Kuroda S; Fujiwara T; Shirakawa Y; Yamasaki Y; Yano S; Uno F; Tazawa H; Hashimoto Y; Watanabe Y; Noma K; Urata Y; Kagawa S; Fujiwara T
    Cancer Res; 2010 Nov; 70(22):9339-48. PubMed ID: 21045143
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional characterization connects individual patient mutations in ataxia telangiectasia mutated (ATM) with dysfunction of specific DNA double-strand break-repair signaling pathways.
    Keimling M; Volcic M; Csernok A; Wieland B; Dörk T; Wiesmüller L
    FASEB J; 2011 Nov; 25(11):3849-60. PubMed ID: 21778326
    [TBL] [Abstract][Full Text] [Related]  

  • 16. L1CAM regulates DNA damage checkpoint response of glioblastoma stem cells through NBS1.
    Cheng L; Wu Q; Huang Z; Guryanova OA; Huang Q; Shou W; Rich JN; Bao S
    EMBO J; 2011 Mar; 30(5):800-13. PubMed ID: 21297581
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dual role of Nbs1 in the ataxia telangiectasia mutated-dependent DNA damage response.
    Lee JH; Lim DS
    FEBS J; 2006 Apr; 273(8):1630-6. PubMed ID: 16623700
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of NBS1 in the modulation of PIKK family proteins ATM and ATR in the cellular response to DNA damage.
    Zhou J; Lim CU; Li JJ; Cai L; Zhang Y
    Cancer Lett; 2006 Nov; 243(1):9-15. PubMed ID: 16530324
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chaperoning the DNA damage response.
    Stracker TH
    FEBS J; 2017 Aug; 284(15):2375-2377. PubMed ID: 28782203
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ataxia-telangiectasia and related diseases.
    Frappart PO; McKinnon PJ
    Neuromolecular Med; 2006; 8(4):495-511. PubMed ID: 17028372
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.